Learn more about the three 2025 ODP Early Stage Investigator Lecture awardees who are poised to become future leaders in prevention research and watch their lectures!
Nilay S. Shah, M.D., M.P.H.
Lecture Title: Cardiovascular Disease Prevention in Asian Americans
Julia Chen-Sankey, Ph.D., M.A.
Lecture Title: Unpacking the Influence of E-Cigarette Marketing Features: Insights into Appeal, Engagement, and Behavior
Michael Fang, Ph.D.
Lecture Title: Type 1 Diabetes Management in the U.S.: Epidemiologic Evidence, Trends, and Emerging Challenges
Nilay S. Shah, M.D., M.P.H.
Northwestern University Feinberg School of Medicine
Learn more about Dr. Shah
Lecture Title
Cardiovascular Disease Prevention in Asian Americans
View the Lecture
June 4, 2025
Resources
-
ESIL-Shah-slides-FINAL-508.pdf (2.46 MB)
About the Lecture
The Asian American population is the fastest-growing group in the United States, expected to number approximately 46 million by 2060. Health research frequently aggregates Asian individuals into a single category, masking clinically significant heterogeneity in health and disease outcomes across various Asian communities. In this lecture, Dr. Shah outlines the science of cardiovascular disease prevention among Asian American populations. His exposition includes emphasizing the epidemiology of cardiovascular health across disaggregated Asian communities, characterizing upstream social and structural factors that influence cardiovascular disease risk in these groups, and discussing evidence for adapted clinical and community-based prevention interventions that build on the unique characteristics of Asian populations. Dr. Shah additionally highlights future directions for cardiovascular prevention for Asian Americans, interventions cited in his own NIH-funded research program.
Julia Chen-Sankey, Ph.D., M.A.
Rutgers School of Public Health
Learn more about Dr. Chen-Sankey
Lecture Title
Unpacking the Influence of E-Cigarette Marketing Features: Insights into Appeal, Engagement, and Behavior
View the Lecture
June 5, 2025
Resources
-
ESIL-Chen-Sankey-Slides-FINAL2-508.pdf (2.85 MB)
About the Lecture
E-cigarette marketing and promotion have significantly contributed to the initiation and sustained use of nicotine e-cigarette products among young people, a priority population for tobacco prevention and control efforts. Gaining a deeper understanding of how specific marketing features—such as flavor descriptors and imagery, price promotions, and the use of young models—impact this group is crucial for developing effective public health policies and prevention programs. In this presentation, Dr. Chen-Sankey examines the predominant marketing themes employed by major e-cigarette brands across various channels, including social media, emails, and magazines. She shares findings from her research that analyze young adults’ visual attention to various e-cigarette marketing features, alongside their perceptions and intentions related to e-cigarette use shaped by these promotional elements. Additionally, Dr. Chen-Sankey explores how attention to and appeal of these marketing features differ between young adults who are naive to tobacco products and those who have established cigarette smoking behaviors. Finally, she discusses the broader implications of these findings, highlighting opportunities for developing impactful policies and public health interventions aimed at reducing e-cigarette-related harms among young people.
Michael Fang, Ph.D.
Johns Hopkins Bloomberg School of Public Health
Learn more about Dr. Fang
Lecture Title
Type 1 Diabetes Management in the U.S.: Epidemiologic Evidence, Trends, and Emerging Challenges
View the Lecture
June 27, 2025
Resources
-
ESIL-Fang-slides-FINAL-v2-508.pdf (2.01 MB)
About the Lecture
Novel technologies and therapies have transformed the management of type 1 diabetes. Today, individuals with type 1 diabetes are living longer than ever before. However, population-based data on the burden, management, and prognosis of type 1 diabetes across the lifespan remain limited. In this talk, Dr. Fang draws on emerging evidence from national health surveys and large electronic health record databases to describe the modern epidemiology of type 1 diabetes in the United States. His talk highlights areas of progress and emerging challenges in type 1 diabetes management, with a focus on glycemic control, obesity, and access to new diabetes technologies.